Commensal bacteria modulate innate immune responses of vaginal epithelial cell multilayer cultures

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Rose II, William A ^a,c   McGowin, Chris L ^b,d   Spagnuolo, Rae Ann ^a   Eaves Pyles, Tonyia D ^a   Popov, Vsevolod L ^b   Pyles, Richard B ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TOLL LIKE RECEPTOR; DIACYLGLYCEROL; FSL 1 LIPOPROTEIN, SYNTHETIC; FSL-1 LIPOPROTEIN, SYNTHETIC; OLIGOPEPTIDE;

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CELL CULTURE; CELL FUNCTION; CELL STRUCTURE; CELL SURFACE; COMMENSALISM; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS JENSENII; LACTOBACILLUS RHAMNOSUS; NONHUMAN; REGULATORY MECHANISM; REPRODUCIBILITY; SEXUALLY TRANSMITTED DISEASE; STAPHYLOCOCCUS EPIDERMIDIS; TIGHT JUNCTION; VAGINA EPITHELIUM; BACTERIUM; BIOSYNTHESIS; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; EPITHELIUM CELL; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MUCOSA; ULTRASTRUCTURE; VAGINA;

LACTOBACILLUS CRISPATUS; STAPHYLOCOCCUS EPIDERMIDIS;

BACTERIA; CELL CULTURE TECHNIQUES; CYTOKINES; DIGLYCERIDES; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNITY, INNATE; LACTOBACILLUS; MUCOUS MEMBRANE; OLIGOPEPTIDES; SEXUALLY TRANSMITTED DISEASES; TOLL-LIKE RECEPTORS; VAGINA;

EID: 84857890792     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032728     Document Type: Article

References (57)

1. Eschenbach DA, Thwin SS, Patton DL, Hooton TM, Stapleton AE, et al. (2000) Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis 30: 901-907.
2. Farage M, Maibach H, (2006) Lifetime changes in the vulva and vagina. Arch Gynecol Obstet 273: 195-202.
3. Hladik F, Sakchalathorn P, Ballweber L, Lentz G, Fialkow M, et al. (2007) Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26: 257-270.
4. Farage MA, Maibach HI, (2011) Morphology and physiological changes of genital skin and mucosa. Curr Probl Dermatol 40: 9-19.
5. Ayehunie S, Cannon C, Lamore S, Kubilus J, Anderson DJ, et al. (2006) Organotypic human vaginal-ectocervical tissue model for irritation studies of spermicides, microbicides, and feminine-care products. Toxicol In Vitro 20: 689-698.
6. Siddique SA, (2003) Vaginal Anatomy and Physiology. J Pelvic Surgery 9: 263-272.
7. Spurbeck RR, Arvidson CG, (2011) Lactobacilli at the front line of defense against vaginally acquired infections. Future Microbiol 6: 567-582.
8. Sobel JD, Chaim W, (1996) Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis. J Clin Microbiol 34: 2497-2499.
9. Coolen MJ, Post E, Davis CC, Forney LJ, (2005) Characterization of microbial communities found in the human vagina by analysis of terminal restriction fragment length polymorphisms of 16 S rRNA genes. Appl Environ Microbiol 71: 8729-8737.
10. Ferris MJ, Norori J, Zozaya-Hinchliffe M, Martin DH, (2007) Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment. J Clin Microbiol 45: 1016-1018.
11. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, et al. (2011) Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A 108 (Suppl 1): 4680-4687.
12. Baeten J, Hassan W, Chohan V, Richardson B, Mandaliya K, et al. (2009) Prospective study of correlates of vaginal Lactobacillus colonization among high-risk HIV-1 seronegative women. Sex Transm Infect.
13. Macklaim JM, Gloor GB, Anukam KC, Cribby S, Reid G, (2011) At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1. Proc Natl Acad Sci U S A 108 (Suppl 1): 4688-4695.
14. Spurbeck RR, Arvidson CG, (2008) Inhibition of Neisseria gonorrhoeae epithelial cell interactions by vaginal Lactobacillus species. Infect Immun 76: 3124-3130.
15. Boskey ER, Cone RA, Whaley KJ, Moench TR, (2001) Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod 16: 1809-1813.
16. Anton G, Rid J, Mylonas I, Friese K, Weissenbacher ER, (2008) Evidence of a TH1-shift of local vaginal inflammatory response during bacterial vaginosis. Infection 36: 147-152.
17. Hillier SL, (1998) The vaginal microbial ecosystem and resistance to HIV. AIDS Res Hum Retroviruses 14 (Suppl 1): S17-21.
18. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, et al. (2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329: 1168-1174.
19. Feldblum PJ, Adeiga A, Bakare R, Wevill S, Lendvay A, et al. (2008) SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS ONE 3: e1474.
20. Padian NS, McCoy SI, Balkus JE, Wasserheit JN, (2010) Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS 24: 621-635.
21. Herbst-Kralovetz MM, Quayle AJ, Ficarra M, Greene S, Rose WA 2nd, et al. (2008) Quantification and comparison of toll-like receptor expression and responsiveness in primary and immortalized human female lower genital tract epithelia. Am J Reprod Immunol 59: 212-224.
22. Langbein L, Grund C, Kuhn C, Praetzel S, Kartenbeck J, et al. (2002) Tight junctions and compositionally related junctional structures in mammalian stratified epithelia and cell cultures derived therefrom. Eur J Cell Biol 81: 419-435.
23. Iavazzo C, Vogiatzi C, Falagas ME, (2008) A retrospective analysis of isolates from patients with vaginitis in a private Greek obstetric/gynecological hospital (2003-2006). Med Sci Monit 14: CR228-231.
24. Gillan DC, Speksnijder AG, Zwart G, De Ridder C, (1998) Genetic diversity of the biofilm covering Montacuta ferruginosa (Mollusca, bivalvia) as evaluated by denaturing gradient gel electrophoresis analysis and cloning of PCR-amplified gene fragments coding for 16 S rRNA. Appl Environ Microbiol 64: 3464-3472.
25. Eckstein P, Jackson MC, Millman N, Sobrero AJ, (1969) Comparison of vaginal tolerance tests of spermicidal preparations in rabbits and monkeys. J Reprod Fertil 20: 85-93.
26. Barberini F, Correr S, De Santis F, Motta PM, (1991) The epithelium of the rabbit vagina: a microtopographical study by light, transmission and scanning electron microscopy. Arch Histol Cytol 54: 365-378.
27. Patton DL, Sweeney YC, Tsai CC, Hillier SL, (2004) Macaca fascicularis vs. Macaca nemestrina as a model for topical microbicide safety studies. J Med Primatol 33: 105-108.
28. D'Cruz OJ, Erbeck D, Uckun FM, (2005) A study of the potential of the pig as a model for the vaginal irritancy of benzalkonium chloride in comparison to the nonirritant microbicide PHI-443 and the spermicide vanadocene dithiocarbamate. Toxicol Pathol 33: 465-476.
29. Squier CA, Mantz MJ, Schlievert PM, Davis CC, (2008) Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa. J Pharm Sci 97: 9-21.
30. Vincent KL, Bell BA, Johnston RK, Stegall R, Vargas G, et al. (2010) Benzalkonium chloride causes colposcopic changes and increased susceptibility to genital herpes infection in mice. Sex Transm Dis 37: 579-584.
31. Vincent KL, Bell BA, Rosenthal SL, Stanberry LR, Bourne N, et al. (2008) Application of optical coherence tomography for monitoring changes in cervicovaginal epithelial morphology in macaques: potential for assessment of microbicide safety. Sex Transm Dis 35: 269-275.
32. Vincent KL, Bourne N, Bell BA, Vargas G, Tan A, et al. (2009) High resolution imaging of epithelial injury in the sheep cervicovaginal tract: a promising model for testing safety of candidate microbicides. Sex Transm Dis 36: 312-318.
33. Pyles RB, Higgins D, Chalk C, Zalar A, Eiden J, et al. (2002) Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection. J Virol 76: 11387-11396.
34. Ashkar AA, Yao XD, Gill N, Sajic D, Patrick AJ, et al. (2004) Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J Infect Dis 190: 1841-1849.
35. Herbst-Kralovetz MM, Pyles RB, (2006) Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection. J Virol 80: 9988-9997.
36. Catalone BJ, Kish-Catalone TM, Budgeon LR, Neely EB, Ferguson M, et al. (2004) Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides. Antimicrob Agents Chemother 48: 1837-1847.
37. Spencer SE, Valentin-Bon IE, Whaley K, Jerse AE, (2004) Inhibition of Neisseria gonorrhoeae genital tract infection by leading-candidate topical microbicides in a mouse model. J Infect Dis 189: 410-419.
38. Rivera AJ, Frank JA, Stumpf R, Salyers AA, Wilson BA, et al. (2011) Differences between the normal vaginal bacterial community of baboons and that of humans. Am J Primatol 73: 119-126.
39. Zarate G, Santos V, Nader-Macias ME, (2009) Protective effect of vaginal Lactobacillus paracasei CRL 1289 against urogenital infection produced by Staphylococcus aureus in a mouse animal model. Infect Dis Obstet Gynecol 2009: 48358.
40. Jerse AE, Crow ET, Bordner AN, Rahman I, Cornelissen CN, et al. (2002) Growth of Neisseria gonorrhoeae in the female mouse genital tract does not require the gonococcal transferrin or hemoglobin receptors and may be enhanced by commensal lactobacilli. Infect Immun 70: 2549-2558.
41. Muench DF, Kuch DJ, Wu H, Begum AA, Veit SJ, et al. (2009) Hydrogen peroxide-producing lactobacilli inhibit gonococci in vitro but not during experimental genital tract infection. J Infect Dis 199: 1369-1378.
42. Collins KB, Patterson BK, Naus GJ, Landers DV, Gupta P, (2000) Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nat Med 6: 475-479.
43. Hjelm BE, Berta AN, Nickerson CA, Arntzen CJ, Herbst-Kralovetz MM, (2010) Development and characterization of a three-dimensional organotypic human vaginal epithelial cell model. Biol Reprod 82: 617-627.
44. Valore EV, Wiley DJ, Ganz T, (2006) Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect Immun 74: 5693-5702.
45. Santos Rocha C, Lakhdari O, Blottiere HM, Blugeon S, Sokol H, et al. Anti-inflammatory properties of dairy lactobacilli. Inflamm Bowel Dis.
46. Zenhom M, Hyder A, de Vrese M, Heller KJ, Roeder T, et al. Peptidoglycan recognition protein 3 (PglyRP3) has an anti-inflammatory role in intestinal epithelial cells. Immunobiology.
47. Fichorova RN, (2004) Guiding the vaginal microbicide trials with biomarkers of inflammation. J Acquir Immune Defic Syndr 37 (Suppl 3): S184-193.
48. Libby EK, Pascal KE, Mordechai E, Adelson ME, Trama JP, (2008) Atopobium vaginae triggers an innate immune response in an in vitro model of bacterial vaginosis. Microbes Infect 10: 439-446.
49. Losikoff P, Fichorova R, Snyder B, Rodriguez I, Cu-Uvin S, et al. (2007) Genital tract interleukin-8 but not interleukin-1beta or interleukin-6 concentration is associated with bacterial vaginosis and its clearance in HIV-infected and HIV-uninfected women. Infect Dis Obstet Gynecol 2007: 92307.
50. Fan SR, Liu XP, Liao QP, (2008) Human defensins and cytokines in vaginal lavage fluid of women with bacterial vaginosis. Int J Gynaecol Obstet 103: 50-54.
51. Haggerty CL, Totten PA, Ferris M, Martin DH, Hoferka S, et al. (2008) Clinical characteristics of bacterial vaginosis among women testing positive for fastidious bacteria. Sex Transm Infect.
52. Mitchell CM, Balkus J, Agnew KJ, Cohn S, Luque A, et al. (2008) Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines. AIDS Res Hum Retroviruses 24: 667-671.
53. Brandtzaeg P, (2010) Homeostatic impact of indigenous microbiota and secretory immunity. Benef Microbes 1: 211-227.
54. Hemmerling A, Harrison W, Schroeder A, Park J, Korn A, et al. (2010) Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis. Sex Transm Dis 37: 745-750.
55. Liu X, Lagenaur LA, Simpson DA, Essenmacher KP, Frazier-Parker CL, et al. (2006) Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N. Antimicrob Agents Chemother 50: 3250-3259.
56. Zozaya-Hinchliffe M, Lillis R, Martin DH, Ferris MJ, (2010) Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J Clin Microbiol 48: 1812-1819.
57. Eaves-Pyles TD, Wong HR, Odoms K, Pyles RB, (2001) Salmonella flagellin-dependent proinflammatory responses are localized to the conserved amino and carboxyl regions of the protein. J Immunol 167: 7009-7016.